Expression of CD103 identifies human regulatory T-cell subsets

Journal of Allergy and Clinical Immunology

Volumn 118, Issue 6, 2006, Pages 1342-1349

  Allakhverdi, Zoulfia ^a   Fitzpatrick, David ^c   Boisvert, Annie ^a   Baba, Nobuyasu ^b   Bouguermouh, Salim ^b   Sarfati, Marika ^b   Delespesse, Guy ^a  

^a Allergy Laboratory   (Canada)

^b NOTRE DAME HOSPITAL   (Canada)

^c AMGEN INC   (United States)

Author keywords

alloreactive T cells; CD103; CD25; dendritic cells; FoxP3; Human regulatory T cells; neonatal lymphocytes; TGF

Indexed keywords

BIOLOGICAL MARKER; CD103 ANTIGEN; CD4 ANTIGEN; INTERLEUKIN 2 RECEPTOR ALPHA; MESSENGER RNA; TRANSCRIPTION FACTOR FOXP3;

ALLOIMMUNITY; ANIMAL CELL; ANTIGEN EXPRESSION; ARTICLE; BONE MARROW TRANSPLANTATION; CD25+ T LYMPHOCYTE; CD4+ T LYMPHOCYTE; CELL FRACTIONATION; CELL ISOLATION; CONTROLLED STUDY; DENDRITIC CELL; HUMAN; HUMAN CELL; IMMUNOSTIMULATION; IN VITRO STUDY; LYMPHOCYTE CULTURE; MOUSE; NEWBORN; NONHUMAN; PRIORITY JOURNAL; REGULATORY T LYMPHOCYTE; SUPPRESSOR CELL; T LYMPHOCYTE SUBPOPULATION; UMBILICAL CORD BLOOD;

AGE FACTORS; ANTIGENS, CD; BIOLOGICAL MARKERS; CELLS, CULTURED; COCULTURE TECHNIQUES; HUMANS; INTEGRIN ALPHA CHAINS; INTERLEUKIN-2 RECEPTOR ALPHA SUBUNIT; LYMPHOCYTE ACTIVATION; T-LYMPHOCYTE SUBSETS; T-LYMPHOCYTES, REGULATORY;

EID: 33845213654     PISSN: 00916749     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jaci.2006.07.034     Document Type: Article

References (37)

1. Piccirillo C.A., and Shevach E.M. Naturally-occurring CD4+CD25+ immunoregulatory T cells: central players in the arena of peripheral tolerance. Semin Immunol 16 (2004) 81-88
2. Zenclussen A.C., Gerlof K., Zenclussen M.L., Sollwedel A., Bertoja A.Z., Ritter T., et al. Abnormal T-cell reactivity against paternal antigens in spontaneous abortion: adoptive transfer of pregnancy-induced CD4+CD25+ T regulatory cells prevents fetal rejection in a murine abortion model. Am J Pathol 166 (2005) 811-822
3. Stock P., Akbari O., Berry G., Freeman G.J., Dekruyff R.H., and Umetsu D.T. Induction of T helper type 1-like regulatory cells that express Foxp3 and protect against airway hyper-reactivity. Nat Immunol 5 (2004) 1149-1156
4. Akdis M., Verhagen J., Taylor A., Karamloo F., Karagiannidis C., Crameri R., et al. Immune responses in healthy and allergic individuals are characterized by a fine balance between allergen-specific T regulatory 1 and T helper 2 cells. J Exp Med 199 (2004) 1567-1575
5. Belkaid Y., and Rouse B.T. Natural regulatory T cells in infectious disease. Nat Immunol 6 (2005) 353-360
6. Chen T.C., Cobbold S.P., Fairchild P.J., and Waldmann H. Generation of anergic and regulatory T cells following prolonged exposure to a harmless antigen. J Immunol 172 (2004) 5900-5907
7. Wei W.Z., Morris G.P., and Kong Y.C. Anti-tumor immunity and autoimmunity: a balancing act of regulatory T cells. Cancer Immunol Immunother 53 (2004) 73-78
8. Hori S., Nomura T., and Sakaguchi S. Control of regulatory T cell development by the transcription factor Foxp3. Science 299 (2003) 1057-1061
9. Fontenot J.D., and Rudensky A.Y. A well adapted regulatory contrivance: regulatory T cell development and the forkhead family transcription factor Foxp3. Nat Immunol 6 (2005) 331-337
10. Kriegel M.A., Lohmann T., Gabler C., Blank N., Kalden J.R., and Lorenz H.M. Defective suppressor function of human CD4+ CD25+ regulatory T cells in autoimmune polyglandular syndrome type II. J Exp Med 199 (2004) 1285-1291
11. Ruprecht C.R., Gattorno M., Ferlito F., Gregorio A., Martini A., Lanzavecchia A., et al. Coexpression of CD25 and CD27 identifies FoxP3+ regulatory T cells in inflamed synovia. J Exp Med 201 (2005) 1793-1803
12. Roncarolo M.G., Gregori S., and Levings M. Type 1 T regulatory cells and their relationship with CD4+CD25+ T regulatory cells. Novartis Found Symp 252 (2003) 115-131 203-10
13. Vieira P.L., Christensen J.R., Minaee S., O'Neill E.J., Barrat F.J., Boonstra A., et al. IL-10-secreting regulatory T cells do not express Foxp3 but have comparable regulatory function to naturally occurring CD4+CD25+ regulatory T cells. J Immunol 172 (2004) 5986-5993
14. Lehmann J., Huehn J., de la Rosa M., Maszyna F., Kretschmer U., Krenn V., et al. Expression of the integrin alpha Ebeta 7 identifies unique subsets of CD25+ as well as CD25- regulatory T cells. Proc Natl Acad Sci U S A 99 (2002) 13031-13036
15. Huehn J., Siegmund K., Lehmann J.C., Siewert C., Haubold U., Feuerer M., et al. Developmental stage, phenotype, and migration distinguish naive- and effector/memory-like CD4+ regulatory T cells. J Exp Med 199 (2004) 303-313
16. Feng Y., Wang D., Yuan R., Parker C.M., Farber D.L., and Hadley G.A. CD103 expression is required for destruction of pancreatic islet allografts by CD8(+) T cells. J Exp Med 196 (2002) 877-886
17. Johansson-Lindbom B., Svensson M., Pabst O., Palmqvist C., Marquez G., Forster R., et al. Functional specialization of gut CD103+ dendritic cells in the regulation of tissue-selective T cell homing. J Exp Med 202 (2005) 1063-1073
18. Cerf-Bensussan N., Jarry A., Brousse N., Lisowska-Grospierre B., Guy-Grand D., and Griscelli C. A monoclonal antibody (HML-1) defining a novel membrane molecule present on human intestinal lymphocytes. Eur J Immunol 17 (1987) 1279-1285
19. Dujardin H.C., Burlen-Defranoux O., Boucontet L., Vieira P., Cumano A., and Bandeira A. Regulatory potential and control of Foxp3 expression in newborn CD4+ T cells. Proc Natl Acad Sci U S A 101 (2004) 14473-14478
20. Higgins J.M., Mandlebrot D.A., Shaw S.K., Russell G.J., Murphy E.A., Chen Y.T., et al. Direct and regulated interaction of integrin alphaEbeta7 with E-cadherin. J Cell Biol 140 (1998) 197-210
21. Suffia I., Reckling S.K., Salay G., and Belkaid Y. A role for CD103 in the retention of CD4+CD25+ Treg and control of Leishmania major infection. J Immunol 174 (2005) 5444-5455
22. Allakhverdi Z., Bouguermouh S., Rubio M., and Delespesse G. Adjuvant activity of pollen grains. Allergy 60 (2005) 1157-1164
23. Lecoeur H., de Oliveira-Pinto L.M., and Gougeon M.L. Multiparametric flow cytometric analysis of biochemical and functional events associated with apoptosis and oncosis using the 7-aminoactinomycin D assay. J Immunol Methods 265 (2002) 81-96
24. Risdon G., Gaddy J., Horie M., and Broxmeyer H.E. Alloantigen priming induces a state of unresponsiveness in human umbilical cord blood T cells. Proc Natl Acad Sci U S A 92 (1995) 2413-2417
25. Jonuleit H., Schmitt E., Schuler G., Knop J., and Enk A.H. Induction of interleukin 10-producing, nonproliferating CD4(+) T cells with regulatory properties by repetitive stimulation with allogeneic immature human dendritic cells. J Exp Med 192 (2000) 1213-1222
26. Rao P.E., Petrone A.L., and Ponath P.D. Differentiation and expansion of T cells with regulatory function from human peripheral lymphocytes by stimulation in the presence of TGF-β. J Immunol 174 (2005) 1446-1455
27. Sigmundsdottir H., Johnston A., Gudjonsson J.E., and Valdimarsson H. Differential effects of interleukin 12 and interleukin 10 on superantigen-induced expression of cutaneous lymphocyte-associated antigen (CLA) and alphaEbeta7 integrin (CD103) by CD8+ T cells. Clin Immunol 111 (2004) 119-125
28. Joffre O., Gorsse N., Romagnoli P., Hudrisier D., and van Meerwijk J.P. Induction of antigen-specific tolerance to bone marrow allografts with CD4+CD25+ T lymphocytes. Blood 103 (2004) 4216-4221
29. Yamagiwa S., Gray J.D., Hashimoto S., and Horwitz D.A. A role for TGF-beta in the generation and expansion of CD4+CD25+ regulatory T cells from human peripheral blood. J Immunol 166 (2001) 7282-7289
30. Robinson P.W., Green S.J., Carter C., Coadwell J., and Kilshaw P.J. Studies on transcriptional regulation of the mucosal T-cell integrin alphaEbeta7 (CD103). Immunology 103 (2001) 146-154
31. Huber S., Schramm C., Lehr H.A., Mann A., Schmitt S., Becker C., et al. Cutting edge: TGF-beta signaling is required for the in vivo expansion and immunosuppressive capacity of regulatory CD4+CD25+ T cells. J Immunol 173 (2004) 6526-6531
32. Fantini M.C., Becker C., Monteleone G., Pallone F., Galle P.R., and Neurath M.F. Cutting edge: TGF-beta induces a regulatory phenotype in CD4+CD25- T cells through Foxp3 induction and down-regulation of Smad7. J Immunol 172 (2004) 5149-5153
33. Bassuny W.M., Ihara K., Sasaki Y., Kuromaru R., Kohno H., Matsuura N., et al. A functional polymorphism in the promoter/enhancer region of the FOXP3/Scurfin gene associated with type 1 diabetes. Immunogenetics 55 (2003) 149-156
34. Riemann H., Schwarz A., Grabbe S., Aragane Y., Luger T.A., Wysocka M., et al. Neutralization of IL-12 in vivo prevents induction of contact hypersensitivity and induces hapten-specific tolerance. J Immunol 156 (1996) 1799-1803
35. Zhang G.X., Xu H., Kishi M., Calida D., and Rostami A. The role of IL-12 in the induction of intravenous tolerance in experimental autoimmune encephalomyelitis. J Immunol 168 (2002) 2501-2507
36. Barrat F.J., Cua D.J., Boonstra A., Richards D.F., Crain C., Savelkoul H.F., et al. In vitro generation of interleukin 10-producing regulatory CD4(+) T cells is induced by immunosuppressive drugs and inhibited by T helper type 1 (Th1)- and Th2-inducing cytokines. J Exp Med 195 (2002) 603-616
37. Ballen K.K. New trends in umbilical cord blood transplantation. Blood 105 (2005) 3786-3792